ABBV vs AMGN
As of Sep 20, 2026, AbbVie (ABBV) scores 7.8/10 and Amgen (AMGN) 5.0/10 on AlphaStocks' five-model composite, so ABBV scores higher. ABBV trades 102% above its model fair value; AMGN trades 15% above its model fair value.
ABBV
AbbVie Inc.
7.8
Strong Buy
$263.86
AMGN
AMGEN INC
5.0
Consider Buy
$385.61
ABBV vs AMGN: Which is the Better Investment?
AbbVie Inc. (ABBV) scores 7.8/10 while AMGEN INC (AMGN) scores 5.0/10 on AlphaStocks' composite model. AbbVie Inc. has the higher composite rating of Strong Buy. On a P/E basis, AMGEN INC trades at 27.1x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | ABBV | AMGN |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 7.8/10▲ | 5.0/10 |
| Rating | Strong Buy▲ | Consider Buy |
| Price | $263.86 | $385.61 |
| P/E Ratio | 110.7 | 27.1▲ |
| ROE | -143.0% | 22.7%▲ |
| Market Cap | $468B | $210B |
| Fair Value | $130.53 | $336.20 |
| Dividend Yield | 2.7%▲ | 2.6% |
| Sector Rank | #2 of 168▲ | #112 of 168 |
| Model Verdicts | ||
| Piotroski | Strong | Strong |
| Buffett | Strong▲ | Neutral |
| Graham | Neutral▲ | Caution |
| Lynch | Neutral | Neutral |
| Greenblatt | Neutral | Neutral |
Related comparisons
ABBV vs AMGN: Which Stock Scores Higher?
AbbVie Inc. (ABBV) and AMGEN INC (AMGN) are both in the Health Care sector. ABBV currently leads with a composite score of 7.8/10 (Strong Buy) compared to AMGN's 5.0/10 (Consider Buy).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer